IRB Barcelona collaborates with Amazon to develop a computational tool speeding up research against SARS-CoV-2 Blog Post

IRB Barcelona’s Structural Bioinformatics and Network Biology Laboratory, led by ICREA researcher Patrick Aloy at the Barcelona Science Park, has joined forces with Amazon Sciences to develop a computational tool, using artificial intelligence, that generates a open access database that includes all the published scientific results related to the treatment of SARS-CoV-2.

 

AECC backs cancer research involving 3D models at IRB Barcelona Blog Post

The Asociación Española Contra el Cáncer (AECC) –in collaboration with Cancer Research UK (CRUK) and the Fondazione AIRC per la Ricerca sul Cancro (AIRC)– has awarded more than €500,000 euros of funding to an IRB Barcelona project, within the framework of the Accelerator Awards call.  the project will allow researchers to study the complexity and heterogeneity of cancer using culturable mini-cancers, also known as organoids, derived from patients.

 

Núria Montserrat wins Íñigo Álvarez de Toledo Award for Basic Research Blog Post

Núria Montserrat, ICREA research professor and principal investigator of the “Pluripotency for organ regeneration group” at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park, has unanimously won the XXXI Íñigo Álvarez de Toledo Award for Basic Research granted by the Fundación Renal Íñigo Álvarez de Toledo (FRIA). 

 

IBEC and EMBL brought together more than 150 worldwide experts to debate on the medicine of the future Blog Post

This week, the EMBL-IBEC Winter Conference –organised by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL)– brought together more than 200 international experts in the field of bioengineering at La Pedrera building in Barcelona. At the opening of the event, which was led by the mayor Ada Colau, attention was drawn to Barcelona’s consolidation as an international centre of research and knowledge.

 

Núria López-Bigas receives the National ‘Doctores Diz Pintado’ Cancer Research Prize Blog Post

Núria López-Bigas, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, has received the IX National ‘Doctores Diz Pintado’ Cancer Research Prize for her career path. The researcher is the first female scientist to be presented with this prize, which is presented every year by the Fundación de Investigación del Cáncer de la Universidad de la Salamancaa (FICUS)-Centro de Investigación del Cáncer (USAL-CSIC)  to promote and acknowledge the contribution of young Spanish researchers to Cancer Research.

 

Launch of the ODISSeA Postgraduate Programme on Organ Donation to train experts in Southeast Asia Blog Post

About three hundred experts from Malaysia, Myanmar, Philippines and Thailand will be the first generation to complete the ODISSeA Postgraduate Programme in Organ Donation. This initiative is carried out as part of the project ODISSeA, led by the University of Barcelona and promote by DTI Foundation–Donation & Transplantation Institute, based in the Barcelona Science Park, to boost highly specialized training among professionals in this field to the countries of Southeast Asia.

 

Researchers from the CNAG-CRG develop a new classification system for tumours Blog Post

Based on the largest study of cancer patients of its kind, scientists at the Centre Nacional d’Anàlisi Genòmica (CNAG-CRG), located in the Barcelona Science Park, have created a new way of classifying tumours. Clinicians can use genome sequencing to assign their patients’ tumours to one of sixteen groups in the new classification system, ten of which provide important information for the diagnosis and treatment of the disease, like whether an individual will respond to immunotherapy. The work is published in PLOS Computational Biology.

 

The University of Barcelona bestows an accolade on Esteve Blog Post

In an event held in the Great Hall of the Historic Building of the University of Barcelona, Esteve Pharmaceuticals received an accolade for its long history of collaboration in research, development and innovation. The pharmaceutical group –which has its Drug Discovery and Preclinical Development Center at the Barcelona Science Park– sees recognized his commitment to collaborative innovation to provide solutions to medical needs of high social impact.